Journal Policies

OPEN ACCESS POLICY

Our Open Access Policy follows the principles of the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/). Annals of Medical Research applies the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License to the articles we publish. By submitting your paper for publication, you agree to have the CC BY-NC-ND license applied to your work.

Under this Open Access license, you as the author grant permission for others to copy, distribute, or reuse your article’s content for non-commercial purposes, free of charge, provided that proper attribution is given to you as the author and the original source. The corresponding author must sign the Creative Commons License Agreement once their article is accepted.

All journal content can be accessed freely at https://annalsmedres.org/index.php/aomr.

COPYRIGHT POLICY

Annals of Medical Research requires each submission to be accompanied by a Copyright Agreement and Acknowledgement of Authorship Form (available for download at https://www.annalsmedres.org).

When using previously published content, including figures, tables, or any other material in both print and electronic formats, authors must obtain permission from the copyright holder. The legal, financial, and criminal liabilities related to the use of such content are the responsibility of the author(s).

By signing this form, authors retain the copyright to their work and agree that, if the article is accepted for publication by Annals of Medical Research, it will be licensed under the Creative Commons Attribution 4.0 International License (CC BY-NC-ND).


For more details, visit: https://creativecommons.org/licenses/by-nc-nd/4.0/.

PRICE POLICY

Annals of Medical Research is an open-access journal, and until now, the journal's expenses have been covered by its own funds. However, starting from June 15th, 2021, authors will be required to pay an article processing fee to ensure timely evaluation, as well as better consultancy and editing services.

  • Article Processing Fee: TL 1500 (Turkish Liras) or the equivalent in USD for all articles.

  • This fee must be paid in advance before consultancy and editing services are provided.

  • The fee is non-refundable if the author withdraws the article at any stage, for any reason, or if the article is rejected.

  • Article processing fee exemptions are not available for any author.

  • This fee is unrelated to the voluntary scientific evaluations performed by the journal's editors and reviewers.

The Editor-in-Chief reserves the right to reject articles without sending them for peer review.
Annals of Medical Research has no legal or financial liability regarding these fees.

Bank Account Information for Article Processing Fee

  • Liable Corporation: Inonu University Faculty of Medicine

  • Account Name: İnönü Üniversitesi Turgut Özal Tıp Merkezi Döner Sermaye İşletme Müdürlüğü

  • IBAN for TL (Ziraat Bank): TR 32 0001 0014 9035 0098 2350 18

  • Swift Code for USD: TC2B 2A

Please include the article number in the bank transfer description when making the payment.

ADVERTISING POLICY 

Annals of Medical Research accepts digital advertisements on its website, provided they are approved by the journal’s Editorial Board and management. All advertisements will be clearly labeled as such. Advertisers have no influence over editorial decisions or the journal’s advertising policies.

For advertising inquiries, please reach out to the Editorial Office.

REVISION PROCESS

Manuscripts requiring "minor revision" or "major revision" will receive a decision letter from the Editor-in-Chief, outlining the reviewers’ and editors’ comments along with a deadline for resubmission.

Submission of Revised Manuscripts

Authors must submit a detailed "Response to the Reviewers" document along with the revised manuscript. This document should address each reviewer’s comment individually, explaining the revisions made and specifying the corresponding line numbers in the manuscript. Additionally, an annotated version of the main document highlighting the changes should be provided.

Timeliness

Revised manuscripts must be submitted within the deadline stated in the decision letter. Missing the deadline may result in the rejection of the revision. If additional time is required, authors must request an extension before the original deadline expires.

AUTHORSHIP POLICY

Annals of Medical Research follows the International Committee of Medical Journal Editors (ICMJE) guidelines for authorship. To qualify as an author, individuals must meet all four of the following criteria:

  • Substantial contributions to the conception or design of the work, or the acquisition, analysis, or interpretation of data; AND

  • Drafting or critically revising the work for important intellectual content; AND

  • Final approval of the version to be published; AND

  • Accountability for all aspects of the work, ensuring accuracy and integrity.

Author Contributions and Transparency


Authors should be able to identify each co-author’s contributions and ensure proper acknowledgment. The Contributor Roles Taxonomy (CRediT) may be used during submission to specify individual contributions, as agreed upon by all authors. The final article will include an authorship contribution statement reflecting these roles.

Authors must have confidence in the integrity and ethical conduct of their co-authors’ work, ensuring that the research, data, and results presented are accurate and reliable.

Acknowledgment of Non-Authors


Individuals who do not meet all four authorship criteria should not be listed as authors but may be acknowledged on the title page for their contributions to the research.

Authorship Ethics and Misconduct


The journal does not accept ghost, guest, or honorary authorship. If misconduct is suspected, the submission will be suspended, and the relevant COPE flowchart and COPE Policy on authorship and contributorship will be followed. All authors must complete the Authorship Contribution Form to confirm adherence to ICMJE criteria.

Change of Authorship

Requests for changes in authorship, including the addition, removal, or reordering of authors, must be submitted to the editorial office with a signed letter explaining the reason for the change. The letter must be signed by all listed authors, including those being removed.

The Editorial Board will review all requests in accordance with COPE flowchart guidelines, ensuring a transparent and consistent process that upholds the integrity of the research and the credibility of all contributors.

The Role of Artificial Intelligence (AI) in Manuscript Preparation

Annals of Medical Research follows the Committee on Publication Ethics (COPE) guidelines regarding the use of AI and AI-assisted technologies in manuscript preparation. Authorship entails responsibilities that only humans can fulfill, and authors are accountable for the originality and integrity of their work.

AI tools may be used for language editing; however, their use must be explicitly acknowledged in the manuscript. AI cannot be listed as an author, as authorship requires intellectual contributions, critical reasoning, and accountability—elements that AI cannot provide. Maintaining these standards is essential to preserving the quality and originality of published research.

Conflict of Interest Policy

Annals of Medical Research adheres to international editorial standards, including those set by ICMJE, COPE, WAME, and other organizations, to ensure transparency and integrity in the publication process.

A conflict of interest arises when an author, reviewer, or editor has competing interests—such as financial, personal, political, or academic—that could unduly influence their objectivity in manuscript submission, review, or editorial decisions.

Disclosure Requirements:

  • All contributing authors must complete and submit the ICMJE Conflict of Interest Disclosure Form. Any conflicts, whether financial or otherwise, must also be stated at the end of the manuscript.

  • Reviewers and editors must disclose any conflicts that could affect their impartiality. If a reviewer or editor has a conflict of interest, they must recuse themselves from the manuscript's evaluation.

  • Editors, including the Editor-in-Chief, Managing Editor, and Section Editors, may submit their own manuscripts but are excluded from the editorial decision-making process for their work. Final acceptance of such manuscripts requires approval from at least two external reviewers.

To maintain a fair and unbiased peer-review process, authors must not contact section editors regarding their manuscripts. All inquiries should be directed to the editorial office. The journal follows a double-anonymized peer review, ensuring that authors and reviewers remain anonymous to each other.

Any potential conflicts of interest involving editors, authors, or reviewers will be addressed following COPE flowcharts and ICMJE recommendations.

Financial Disclosure

Annals of Medical Research requires authors to disclose any financial support received for their research. This information must be included in the funding statement when submitting the manuscript.

The funding statement should specify:

  • The names of funding agencies,

  • Grant numbers (if applicable),

  • The role of each funder in the research,

If a funder had no involvement in the research, this must also be clearly stated. Providing this information ensures transparency and helps readers assess potential biases or conflicts of interest.

Post-Publication Corrections, Retractions, and Article Removal

Correction Requests

All post-publication correction requests are subject to editorial review. The Editorial Board evaluates the necessity and appropriateness of corrections based on the nature of the error, its impact on the article, and the supporting evidence. If approved, the correction will be made in the journal’s archive. The journal follows the ICMJE and COPE guidelines.

If a misconduct allegation is raised by a whistleblower or through other means, the Editorial Board will follow the COPE flowchart for addressing concerns. For issues arising on public platforms, such as social media, the journal will act in accordance with COPE’s guidance on responding to whistleblowers. In complex cases, an ombudsperson may be assigned to facilitate resolution.

To ensure a thorough and fair investigation, the journal may collaborate with other editors-in-chief or notify relevant institutions regarding suspected research misconduct. If ethical misconduct is confirmed, the journal may issue a retraction notice, clearly marking the article as retracted in the journal archive and relevant indexes.

Article Withdrawal (Pre-Publication)

Withdrawal applies only to articles in press, which are early versions of articles that may contain errors, accidental duplicate submissions, or ethical violations (e.g., multiple submissions, fraudulent data, or plagiarism). Withdrawn articles will have their HTML and PDF content removed, replaced by a statement indicating the withdrawal and linking to the journal’s withdrawal policy.

Article Retraction (Post-Publication)

Retractions are issued for serious ethical violations, such as plagiarism, data fabrication, authorship fraud, or publication without co-author consent. Retraction notices include:

  • A formal retraction note titled “Retraction: [Article Title],” published in a subsequent issue.

  • A watermark on the PDF of the original article, marking it as "Retracted."

  • A removal of the HTML version, ensuring transparency in corrections while preserving academic integrity.

Article Removal (Legal & Safety Concerns)

In rare cases, an article may need to be permanently removed from the journal’s online database due to legal issues, court orders, defamation, or significant health risks. While the metadata (title and authors) will be retained, the article content will be replaced with a legal notice explaining the removal.

Article Replacement

If an article poses a serious health risk, authors may request a replacement with a corrected version. In such cases, a retraction notice will be published with a link to the revised article, ensuring a transparent record of updates.

Appeals and Complaint

The journal handles appeals and complaints in accordance with COPE guidelines to ensure a fair and transparent process. Authors with concerns should contact the editorial office directly. The editorial board will review each case and make decisions based on COPE recommendations.

The editor-in-chief holds the final authority in the decision-making process. In cases where internal resolution is not possible, an ombudsperson may be assigned. The journal is committed to maintaining the integrity of the scientific record throughout the appeals and complaints process.

Permission Policy

The journal's content is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).

This license allows users to download and share the journal's content for non-commercial purposes only, provided that proper credit is given to the original author and the journal. However, users are not allowed to alter, transform, or build upon the work in any way, and no derivative works may be made from the journal’s content.

For commercial use of the journal's content, permission must be obtained from İnönü University, which may impose fees or restrictions.

Data Sharing Policy

As of January 1, 2019, a data sharing statement is required for the registration of clinical trials. Authors must include a data sharing statement in articles reporting clinical trial results. This statement should address the following points in accordance with the ICMJE data sharing policy:

  • Whether individual deidentified participant data will be shared

  • Specific data that will be made available

  • Whether additional related documents will be provided

  • When the data will become accessible and for how long

  • Criteria for data access, including eligible users, intended purposes, and mechanisms for obtaining the data

Authors are encouraged to review ICMJE data sharing examples at:
ICMJE Clinical Trial Registration

When submitting a clinical trial to Annals of Medical Research:

  • Authors must register the trial in a publicly accessible registry, following ICMJE recommendations and the guidelines above.

  • The registry name and registration number must be provided on the Title Page during the initial submission.

  • A data sharing statement must also be included on the Title Page, even if the authors do not plan to share the data.

The journal’s clinical trial and data sharing policy applies to articles submitted from February 2025 onward.

Self-Archiving Policy

Authors are allowed to self-archive their published work on institutional or personal websites, as well as in open-access repositories. When doing so, they must properly cite the original publication and include the DOI number. Authors are also encouraged to provide a link to the publisher’s official website to maintain the authenticity and integrity of the scientific record. The version published on the publisher’s website is regarded as the definitive version of record.

Preprint Policy

Annals of Medical Research does not consider preprints as prior publication, meaning authors are allowed to present and discuss their findings on a non-commercial preprint server before submitting their work to the journal.

However, authors must provide the journal with the preprint server deposition of their article, along with its DOI, during the initial submission process.

If the article is accepted and published in the journal, it is the responsibility of the authors to update the archived preprint and link it to the published version of the article. This ensures that readers can easily access the most up-to-date and accurate information.

Disclaimer

The views and opinions expressed in published manuscripts belong solely to the author(s) and do not necessarily reflect those of the editors, editorial board, or publisher. The editors, editorial board, and publisher are not responsible for the content of published manuscripts and do not endorse the views expressed within them.

Authors bear full responsibility for the accuracy and integrity of their work. While the journal serves as a platform for disseminating research to the scientific community, it does not guarantee the validity of the content.